As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...
CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--We are pleased to announce the appointment of John Byrd as VP, Management Consulting at AESARA, a digital-forward Value & ...
Circle Pharma, a company focused on developing macrocycle therapeutics against targets previously considered to be undruggable, has appointed Paul Park, MBA, as its Chief Business Officer. Mr. Park ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback